2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$7.66+$0.06 (+0.72%)
Price as of Oct 22, 2026 7:30 PM EDT- $99.5MMarket Cap
- 108.97%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$7.66+$0.06 (+0.72%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.60 | ||
Change | +$0.10 (+1.28%) | ||
Open | $7.87 | ||
High | $7.87 | ||
Low | $7.44 | ||
Previous Close | $7.92 | ||
Volume | 86,950 | ||
30-Day Average Volume | 144,610 | ||
1-Week Change | 21.29% | ||
1-Month Change | 10.92% | ||
1-Year Change | 108.97% | ||
3-Year Change | 178.87% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.6M | ||
Total Assets | $10.0M | ||
Market Cap | $99.5M | ||
Enterprise Value | $91.3M | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$2.1M | ||
Free Cash Flow | -$1.0M | ||
EBIT | -$2.1M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $6.3M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 47 | ||
P/B | 15 | ||
P/E | -42 | ||
PEG | 8 | ||
Price/Free Cash Flow | -97 | ||
Price/Operating Cash Flow | -97 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue